ConductScience.org, home

Paper42792002PubMed

Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations.

Kalliainen R and 4 others. Antibiotics (Basel), 2026.

Cite this record

ConductScience Library. Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations. Papers, record 42792002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42792002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vancomycin AUC24 Estimation for Children with Bayesian Forecasting and First-Order Equations to Update Dose Recommendations.
Journal
Antibiotics (Basel)
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-09-29

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kalliainen RRosa
2Renko MMarjo
3Sankilampi UUllahttps://orcid.org/0000-0002-0789-9720
4Kokki MMerja
5Ranta VPVeli-Pekkahttps://orcid.org/0009-0007-5992-5517

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Department of Pediatrics and Department of Anesthesiology and Intensive Care, Kuopio University HospitalPubMed

Source PubMed

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139935555Vancomycin Area Under the Curve to Minimum Inhibitory Concentration Ratio for Treatment Effectiveness in Pediatric and Neonatal Staphylococcal Infections: A Systematic Review.J Pediatr Pharmacol Ther2025https://conductscience.org/library/papers/39935555PubMed
234002357Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review.Clin Pharmacokinet2021https://conductscience.org/library/papers/34002357PubMed
323340565Improved vancomycin dosing in children using area under the curve exposure.Pediatr Infect Dis J2013https://conductscience.org/library/papers/23340565PubMed
4950590Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.J Pharmacokinet Biopharm1976https://conductscience.org/library/papers/950590PubMed
524452067Vancomycin monitoring in children using bayesian estimation.Ther Drug Monit2014https://conductscience.org/library/papers/24452067PubMed
626582878Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.J Pediatric Infect Dis Soc2015https://conductscience.org/library/papers/26582878PubMed
730656565Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations.Clin Pharmacokinet2019https://conductscience.org/library/papers/30656565PubMed
833068298Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33068298PubMed
939438393Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants.Eur J Drug Metab Pharmacokinet2024https://conductscience.org/library/papers/39438393PubMed
1034671937An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients.Clin Pharmacokinet2022https://conductscience.org/library/papers/34671937PubMed
1118703997Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children.Pediatr Res2009https://conductscience.org/library/papers/18703997PubMed
1226378371Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia.Ther Drug Monit2015https://conductscience.org/library/papers/26378371PubMed
1340715988A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin Therapy.Pharmacotherapy2025https://conductscience.org/library/papers/40715988PubMed
148574501Adaptive control of drug dosage regimens using maximum a posteriori probability Bayesian fitting.Int J Clin Pharmacol Ther1995https://conductscience.org/library/papers/8574501PubMed
1536222533Association between Vancomycin Pharmacokinetic Parameters and Clinical and Microbiological Efficacy in a Cohort of Neonatal Patients.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/36222533PubMed
1634145165Implementation of Vancomycin Therapeutic Monitoring Guidelines: Focus on Bayesian Estimation Tools in Neonatal and Pediatric Patients.Ther Drug Monit2022https://conductscience.org/library/papers/34145165PubMed
1738533999Vancomycin AUC0-24 estimation using first-order pharmacokinetic methods in pediatric patients.Pharmacotherapy2024https://conductscience.org/library/papers/38533999PubMed
1830833429Revising Pediatric Vancomycin Dosing Accounting for Nephrotoxicity in a Pharmacokinetic-Pharmacodynamic Model.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30833429PubMed
1942194175Vancomycin Therapeutic Drug Monitoring, Clinical Outcomes and Population Pharmacokinetic Model Evaluation in Neonates.Children (Basel)2026https://conductscience.org/library/papers/42194175PubMed
2032191793
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Am J Health Syst Pharm2020https://conductscience.org/library/papers/32191793PubMed

See all 25 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42792002

GET https://conductscience.org/api/papers/v1/42792002/references?page=2